BioSpace News Archive

New York City, NY: April 08, 2020 – Published: The demand in the global cell therapy market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory framework is

New York City, NY: April 08, 2020 – Published: The demand in the global chlamydia infection therapeutics market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regu

New York City, NY: April 08, 2020 – Published: The demand in the global cold pain therapy market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory framewor

New York City, NY: April 08, 2020 – Published: The demand in the global colon cancer market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory framework is

New York City, NY: April 08, 2020 – Published: The demand in the global colorectal cancer diagnosis and therapeutics market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a pre

New York City, NY: April 08, 2020 – Published: The demand in the global compounding pharmacies market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory fra

New York City, NY: April 08, 2020 – Published: The demand in the global computed tomography scan market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications. On the other hand, the absence of a predefined regulatory f

Alpha Pro Tech, Ltd. announced an update to the status of orders booked for personal protective equipment products in APT’s disposable protective apparel product suite, including the company’s proprietary N-95 Particulate Respirator face mask and face shields.

Myriad Genetics, Inc., a global leader in personalized medicine, announced that due to the impact of the global COVID-19 pandemic, the company is withdrawing its fiscal year 2020 financial guidance.

“During this unprecedented time in recent history, Trillium is working hard to ensure operational continuity to serve patients whose lives are affected by severe diseases while protecting the health of our employees,” said Jan Skvarka, President and Chief Executive Officer of Trillium.